Haemonetics (HAE) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Haemonetics Revenue Highlights

Latest Revenue (Y)

$1.36B

Latest Revenue (Q)

$348.54M

Main Segment (Y)

Hospital

Main Geography (Y)

UNITED STATES

Haemonetics Revenue by Period

Haemonetics Revenue by Year

Date	Revenue	Change
2025-03-29	$1.36B	3.95%
2024-03-30	$1.31B	12.01%
2023-04-01	$1.17B	17.67%
2022-04-02	$993.20M	14.10%
2021-04-03	$870.46M	-11.94%
2020-03-28	$988.48M	2.16%
2019-03-30	$967.58M	7.04%
2018-03-31	$903.92M	2.01%
2017-04-01	$886.12M	-2.59%
2016-04-02	$909.67M	-0.08%
2015-03-28	$910.37M	-3.00%
2014-03-29	$938.51M	5.22%
2013-03-30	$891.99M	22.55%
2012-03-31	$727.84M	7.56%
2011-04-02	$676.69M	4.84%
2010-04-03	$645.43M	7.95%
2009-03-28	$597.88M	15.77%
2008-03-29	$516.44M	14.86%
2007-03-31	$449.61M	7.12%
2006-04-01	$419.73M	9.42%
2005-04-02	$383.60M	5.32%
2004-04-03	$364.23M	8.09%
2003-03-29	$336.96M	5.31%
2002-03-30	$319.97M	8.88%
2001-03-31	$293.86M	5.73%
2000-04-01	$277.92M	-1.48%
1999-04-03	$282.10M	-1.29%
1998-03-28	$285.80M	-7.75%
1997-03-29	$309.80M	11.36%
1996-03-30	$278.20M	6.02%
1995-03-31	$262.40M	5.64%
1994-03-31	$248.40M	-

Haemonetics generated $1.36B in revenue during NA 2025, up 3.95% compared to the previous quarter, and up 137.67% compared to the same period a year ago.

Haemonetics Revenue by Quarter

Date	Revenue	Change
2024-12-28	$348.54M	0.88%
2024-09-28	$345.51M	2.78%
2024-06-29	$336.17M	-2.07%
2024-03-30	$343.29M	2.09%
2023-12-30	$336.25M	5.68%
2023-09-30	$318.18M	2.20%
2023-07-01	$311.33M	2.27%
2023-04-01	$304.42M	-0.29%
2022-12-31	$305.30M	2.63%
2022-10-01	$297.49M	13.78%
2022-07-02	$261.46M	-1.34%
2022-04-02	$265.00M	2.01%
2022-01-01	$259.77M	8.28%
2021-10-02	$239.90M	4.97%
2021-07-03	$228.53M	1.55%
2021-04-03	$225.03M	-6.38%
2020-12-26	$240.37M	14.74%
2020-09-26	$209.49M	7.11%
2020-06-27	$195.58M	-17.99%
2020-03-28	$238.49M	-7.91%
2019-12-28	$258.97M	2.54%
2019-09-28	$252.57M	5.92%
2019-06-29	$238.45M	-4.35%
2019-03-30	$249.29M	0.78%
2018-12-29	$247.36M	2.39%
2018-09-29	$241.58M	5.33%
2018-06-30	$229.35M	-1.80%
2018-03-31	$233.55M	-0.21%
2017-12-30	$234.04M	3.85%
2017-09-30	$225.38M	6.84%
2017-07-01	$210.95M	-7.50%
2017-04-01	$228.07M	0.10%
2016-12-31	$227.84M	3.45%
2016-10-01	$220.25M	4.90%
2016-07-02	$209.96M	-13.66%
2016-04-02	$243.19M	4.20%
2015-12-26	$233.38M	6.23%
2015-09-26	$219.69M	2.94%
2015-06-27	$213.41M	-5.77%
2015-03-28	$226.48M	-2.31%
2014-12-27	$231.83M	1.87%
2014-09-27	$227.58M	1.38%
2014-06-28	$224.49M	-6.89%
2014-03-29	$241.09M	-0.42%
2013-12-28	$242.12M	2.70%
2013-09-28	$235.75M	7.38%
2013-06-29	$219.54M	-12.16%
2013-03-30	$249.94M	1.03%
2012-12-29	$247.40M	13.39%
2012-09-29	$218.18M	23.63%
2012-06-30	$176.47M	-5.46%
2012-03-31	$186.67M	-2.35%
2011-12-31	$191.16M	6.53%
2011-10-01	$179.44M	5.20%
2011-07-02	$170.57M	0.32%
2011-04-02	$170.03M	-3.82%
2011-01-01	$176.79M	5.97%
2010-10-02	$166.83M	2.33%
2010-07-03	$163.04M	-3.59%
2010-04-03	$169.10M	2.38%
2009-12-26	$165.17M	5.16%
2009-09-26	$157.07M	1.94%
2009-06-27	$154.09M	1.11%
2009-03-28	$152.40M	-1.96%
2008-12-27	$155.45M	6.53%
2008-09-27	$145.92M	1.25%
2008-06-28	$144.12M	3.88%
2008-03-29	$138.74M	-

Haemonetics generated $348.54M in revenue during Q3 2025, up 0.88% compared to the previous quarter, and up 109.54% compared to the same period a year ago.

Haemonetics Revenue Breakdown

Haemonetics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 25	Mar 24	Apr 23	Apr 22	Apr 21
Blood Center	$261.12M	$226.82M	$236.16M	$239.61M	-
Hospital	$564.27M	$378.11M	$329.43M	$216.58M	-
Plasma	$535.43M	$563.73M	$427.61M	$414.27M	-
Service	-	$21.63M	$21.42M	$20.81M	$20.76M

Haemonetics's latest annual revenue breakdown by segment (product or service), as of Mar 25: Hospital (41.47%), Plasma (39.35%), and Blood Center (19.19%).

Quarterly Revenue by Product

Product/Service	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Dec 22	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Apr 21	Dec 20	Sep 20	Jun 20	Dec 19	Sep 19	Jun 19
Hospital	$147.23M	$144.25M	$138.38M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Blood Center	$54.75M	$70.73M	$68.80M	$72.92M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Plasma	$126.44M	$134.39M	$138.56M	$83.75M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	-	-	-	$5.23M	$5.59M	$5.04M	$5.77M	$5.37M	$5.41M	$5.14M	$5.44M	$4.95M	$5.27M	$4.97M	$5.34M	$5.08M	$5.20M	$5.28M	$4.87M	-
Hospital Products and Services	-	-	-	-	-	-	-	$93.13M	$92.43M	$90.19M	$83.98M	$77.89M	$80.27M	$54.07M	$52.54M	$46.20M	$51.61M	$51.10M	$48.80M	-
Plasma Products and Services	-	-	-	-	-	-	-	$153.90M	$143.16M	$118.35M	$116.35M	$102.08M	$90.51M	$123.51M	$97.71M	$88.71M	$141.23M	$135.85M	$129.75M	-
Blood Center Products and Services	-	-	-	-	-	-	-	$58.27M	$61.90M	$52.92M	$59.44M	$59.93M	$57.75M	$62.79M	$59.23M	$60.67M	$66.13M	$65.61M	$59.91M	-

Haemonetics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Hospital (44.83%), Plasma (38.50%), and Blood Center (16.67%).

Haemonetics Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 25	Mar 24	Apr 23	Apr 22	Apr 21
JAPAN	$62.41M	$58.09M	$61.30M	$75.56M	$77.68M
Europe	$175.66M	$160.14M	$156.68M	$163.52M	$159.08M
Asia	$92.31M	$107.54M	$104.14M	$110.80M	$105.82M
UNITED STATES	$1.01B	$970.01M	$842.90M	$639.32M	$522.61M
Other Country or Region	$19.54M	$13.28M	$3.65M	$3.99M	$5.28M
Service	-	-	-	$20.81M	-
Blood Center	-	-	-	$236.16M	-
Hospital	-	-	-	$329.43M	-
Plasma	-	-	-	$427.61M	-

Haemonetics's latest annual revenue breakdown by geography, as of Mar 25: UNITED STATES (74.29%), Europe (12.91%), Asia (6.78%), JAPAN (4.59%), and Other Country or Region (1.44%).

Quarterly Revenue by Country

Country	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Dec 22	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Dec 20	Sep 20	Jun 20	Dec 19	Sep 19	Jun 19	Mar 19
Asia	$21.16M	$25.60M	$25.77M	$26.83M	$30.93M	$27.73M	$22.04M	$25.45M	$27.86M	$24.42M	$30.43M	$26.77M	$25.95M	$29.05M	$26.17M	$22.38M	$29.44M	$30.19M	$28.64M	-
Europe	$42.28M	$44.16M	$41.99M	$45.05M	$37.03M	$38.67M	$39.39M	$39.10M	$41.85M	$40.46M	$41.54M	$41.18M	$43.34M	$41.87M	$38.65M	$43.02M	$40.98M	$38.07M	$36.75M	-
UNITED STATES	$248.29M	$257.67M	$256.06M	$245.78M	$250.80M	$236.34M	$237.07M	$224.10M	$211.72M	$182.00M	$167.27M	$152.11M	$141.03M	$147.61M	$123.98M	$111.01M	$167.24M	$161.88M	$156.38M	-
Other Country or Region	$2.77M	$4.94M	$5.27M	$9.15M	$2.65M	$426.00K	$1.06M	$1.09M	$921.00K	$703.00K	$609.00K	$1.03M	$992.00K	$986.00K	$1.04M	$2.33M	$2.04M	$2.04M	$1.22M	-
JAPAN	$16.11M	$16.17M	$16.42M	$16.48M	$14.82M	$15.01M	$11.77M	$15.55M	$15.13M	$13.88M	$19.92M	$18.81M	$17.22M	$20.85M	$19.64M	$16.83M	$19.27M	$20.38M	$15.47M	$17.98M
Americas Blood Center and Hospital and Asia - Pacific	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$86.48M
EMEA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$46.47M
North America Plasma	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$100.53M

Haemonetics's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (75.10%), Europe (12.79%), Asia (6.40%), JAPAN (4.87%), and Other Country or Region (0.84%).

Haemonetics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
COO	Cooper Companies	$3.90B	$964.70M
ATR	AptarGroup	$3.58B	$887.30M
ICUI	ICU Medical	$2.38B	$629.80M
IART	Integra LifeSciences	$1.61B	$382.65M
HAE	Haemonetics	$1.36B	$348.54M
CNMD	CONMED	$1.31B	$321.26M
MMSI	Merit Medical Systems	$1.30B	$355.35M
ANGO	AngioDynamics	$303.91M	$72.00M

HAE Revenue FAQ

What is Haemonetics’s yearly revenue?

Haemonetics's yearly revenue for 2025 was $1.36B, representing an increase of 3.95% compared to 2024. The company's yearly revenue for 2024 was $1.31B, representing an increase of 12.01% compared to 2023. HAE's yearly revenue for 2023 was $1.17B, representing an increase of 17.67% compared to 2022.

What is Haemonetics’s quarterly revenue?

Haemonetics's quarterly revenue for Q3 2025 was $348.54M, a 0.88% increase from the previous quarter (Q2 2025), and a 3.66% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $345.51M, a 2.78% increase from the previous quarter (Q1 2025), and a 8.59% increase year-over-year (Q2 2024). HAE's quarterly revenue for Q1 2025 was $336.17M, a -2.07% decrease from the previous quarter (Q4 2024), and a 7.98% increase year-over-year (Q1 2024).

What is Haemonetics’s revenue growth rate?

Haemonetics's revenue growth rate for the last 3 years (2023-2025) was 16.44%, and for the last 5 years (2021-2025) was 56.33%.

What are Haemonetics’s revenue streams?

Haemonetics's revenue streams in r 25 are Blood Center, Hospital, and Plasma. Blood Center generated $261.12M in revenue, accounting 19.19% of the company's total revenue, up 15.12% year-over-year. Hospital generated $564.27M in revenue, accounting 41.47% of the company's total revenue, up 49.24% year-over-year. Plasma generated $535.43M in revenue, accounting 39.35% of the company's total revenue, down -5.02% year-over-year.

What is Haemonetics’s main source of revenue?

For the fiscal year ending Mar 25, the largest source of revenue of Haemonetics was Hospital. This segment made a revenue of $564.27M, representing 41.47% of the company's total revenue.